Dangerous deception--hiding the evidence of adverse drug effects
N Engl J Med
.
2006 Nov 23;355(21):2169-71.
doi: 10.1056/NEJMp068246.
Author
Jerry Avorn
1
Affiliation
1
Harvard Medical School and Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital, Boston, USA.
PMID:
17124012
DOI:
10.1056/NEJMp068246
No abstract available
Publication types
Comment
MeSH terms
Antifibrinolytic Agents / adverse effects*
Aprotinin / adverse effects*
Deception
Drug Approval
Drug Industry*
Humans
Observation
Publication Bias*
Research Design
Substances
Antifibrinolytic Agents
Aprotinin